Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation-Reference-Cited by-同舟云学术

Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation

Published:1998-05 Issue:1 Volume:86 Page:337-343
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Goadsby P.J,Hoskin K.L,Knight Y.E

Publisher

Elsevier BV

Subject

General Neuroscience

Reference56 articles.

1. Berman A. L. (1968) The Brain Stem of the Cat. A Cytoarchitectonic Atlas with Stereotaxic Coordinates. University of Wisconsin Press, London.

2. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels;Bouchelet;Molec. Pharmac.,1996

3. Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater;Brandli;Pain,1996

4. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater;Buzzi;Br. J. Pharmac.,1990

5. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater;Buzzi;Eur. J. Pharmac.,1989

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrophysiological model of trigeminovascular nociception as a tool for experimental study of migraine pharmacotherapy;Russian Journal of Pain;2021

2. Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives;Pain;2020-11-06

3. Acid-sensing ion channel 3 blockade inhibits durovascular and nitric oxide-mediated trigeminal pain;BRIT J PHARMACOL;2020

4. PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?;Pain;2020-03-04

5. Acid‐sensing ion channel 3 blockade inhibits durovascular and nitric oxide‐mediated trigeminal pain;British Journal of Pharmacology;2020-03-02